Literature DB >> 22048124

Cerebrovascular disease, β-amyloid, and cognition in aging.

Natalie L Marchant1, Bruce R Reed, Charles S DeCarli, Cindee M Madison, Michael W Weiner, Helena C Chui, William J Jagust.   

Abstract

The present study evaluated cerebrovascular disease (CVD), β-amyloid (Aβ), and cognition in clinically normal elderly adults. Fifty-four participants underwent magnetic resonance imaging (MRI), Pittsburgh compound B (PIB)-positron emission tomography (PET) imaging, and neuropsychological evaluation. High white matter hyperintensity burden and/or presence of infarct defined CVD status (CVD-: n = 27; CVD+: n = 27). PIB-positron emission tomography ratios of Aβ deposition were extracted using Logan plotting (cerebellar reference). Presence of high levels of Aβ in prespecified regions determined PIB status (PIB-: n = 33; PIB+: n = 21). Executive functioning and episodic memory were measured using composite scales. CVD and Aβ, defined as dichotomous or continuous variables, were unrelated to one another. CVD+ participants showed lower executive functioning (p = 0.001) when compared with CVD- individuals. Neither PIB status nor amount of Aβ affected cognition (ps ≥ 0.45), and there was no statistical interaction between CVD and PIB on either cognitive measure. Within this spectrum of normal aging CVD and Aβ aggregation appear to be independent processes with CVD primarily affecting cognition. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22048124      PMCID: PMC3274647          DOI: 10.1016/j.neurobiolaging.2011.10.001

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  75 in total

Review 1.  Vascular factors and Alzheimer disease.

Authors:  I Skoog; R N Kalaria; M M Breteler
Journal:  Alzheimer Dis Assoc Disord       Date:  1999 Oct-Dec       Impact factor: 2.703

2.  Coronary risk correlates with cerebral amyloid deposition.

Authors:  Bruce R Reed; Natalie L Marchant; William J Jagust; Charles C DeCarli; Wendy Mack; Helena C Chui
Journal:  Neurobiol Aging       Date:  2011-11-10       Impact factor: 4.673

3.  Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.

Authors:  Victor L Villemagne; Kerryn E Pike; Gaël Chételat; Kathryn A Ellis; Rachel S Mulligan; Pierrick Bourgeat; Uwe Ackermann; Gareth Jones; Cassandra Szoeke; Olivier Salvado; Ralph Martins; Graeme O'Keefe; Chester A Mathis; William E Klunk; David Ames; Colin L Masters; Christopher C Rowe
Journal:  Ann Neurol       Date:  2011-01       Impact factor: 10.422

4.  Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.

Authors:  Gaël Chételat; Victor L Villemagne; Kerryn E Pike; Kathryn A Ellis; Pierrick Bourgeat; Gareth Jones; Graeme J O'Keefe; Olivier Salvado; Cassandra Szoeke; Ralph N Martins; David Ames; Colin L Masters; Christopher C Rowe
Journal:  Brain       Date:  2011-02-09       Impact factor: 13.501

5.  Amyloid β1-42 oligomer inhibits myelin sheet formation in vitro.

Authors:  Makoto Horiuchi; Izumi Maezawa; Aki Itoh; Kouji Wakayama; Lee-Way Jin; Takayuki Itoh; Charles Decarli
Journal:  Neurobiol Aging       Date:  2010-07-01       Impact factor: 4.673

6.  Late life cognitive control deficits are accentuated by white matter disease burden.

Authors:  Adriane B V Mayda; Andrew Westphal; Cameron S Carter; Charles DeCarli
Journal:  Brain       Date:  2011-04-10       Impact factor: 13.501

7.  β-Amyloid affects frontal and posterior brain networks in normal aging.

Authors:  Hwamee Oh; Elizabeth C Mormino; Cindee Madison; Amynta Hayenga; Andre Smiljic; William J Jagust
Journal:  Neuroimage       Date:  2010-10-18       Impact factor: 6.556

8.  Identification of pure subcortical vascular dementia using 11C-Pittsburgh compound B.

Authors:  J H Lee; S H Kim; G H Kim; S W Seo; H K Park; S J Oh; J S Kim; H K Cheong; D L Na
Journal:  Neurology       Date:  2011-05-18       Impact factor: 9.910

Review 9.  Vascular risk factors for Alzheimer's disease: an epidemiologic perspective.

Authors:  M M Breteler
Journal:  Neurobiol Aging       Date:  2000 Mar-Apr       Impact factor: 4.673

10.  White matter hyperintensities and cognition: testing the reserve hypothesis.

Authors:  Adam M Brickman; Karen L Siedlecki; Jordan Muraskin; Jennifer J Manly; José A Luchsinger; Lok-Kin Yeung; Truman R Brown; Charles DeCarli; Yaakov Stern
Journal:  Neurobiol Aging       Date:  2009-11-18       Impact factor: 4.673

View more
  59 in total

1.  Coronary risk correlates with cerebral amyloid deposition.

Authors:  Bruce R Reed; Natalie L Marchant; William J Jagust; Charles C DeCarli; Wendy Mack; Helena C Chui
Journal:  Neurobiol Aging       Date:  2011-11-10       Impact factor: 4.673

2.  Dopamine transporter availability in clinically normal aging is associated with individual differences in white matter integrity.

Authors:  Anna Rieckmann; Trey Hedden; Alayna P Younger; Reisa A Sperling; Keith A Johnson; Randy L Buckner
Journal:  Hum Brain Mapp       Date:  2015-11-06       Impact factor: 5.038

3.  Vascular Dementia.

Authors:  Alberto R Ramos; Salim I Dib; Clinton B Wright
Journal:  Curr Transl Geriatr Exp Gerontol Rep       Date:  2013-09-01

4.  Neuroprotective pathways: lifestyle activity, brain pathology, and cognition in cognitively normal older adults.

Authors:  Miranka Wirth; Claudia M Haase; Sylvia Villeneuve; Jacob Vogel; William J Jagust
Journal:  Neurobiol Aging       Date:  2014-02-20       Impact factor: 4.673

5.  Interactive Associations of Vascular Risk and β-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study.

Authors:  Jennifer S Rabin; Aaron P Schultz; Trey Hedden; Anand Viswanathan; Gad A Marshall; Emily Kilpatrick; Hannah Klein; Rachel F Buckley; Hyun-Sik Yang; Michael Properzi; Vaishnavi Rao; Dylan R Kirn; Kathryn V Papp; Dorene M Rentz; Keith A Johnson; Reisa A Sperling; Jasmeer P Chhatwal
Journal:  JAMA Neurol       Date:  2018-09-01       Impact factor: 18.302

6.  Imaging Vascular Disease and Amyloid in the Aging Brain: Implications for Treatment.

Authors:  Sylvia Villeneuve; William J Jagust
Journal:  J Prev Alzheimers Dis       Date:  2015-03

7.  Vascular Burden Score Impacts Cognition Independent of Amyloid PET and MRI Measures of Alzheimer's Disease and Vascular Brain Injury.

Authors:  Charles DeCarli; Sylvia Villeneuve; Pauline Maillard; Danielle Harvey; Baljeet Singh; Owen Carmichael; Evan Fletcher; John Olichney; Sarah Farias; William Jagust; Bruce Reed; Dan Mungas
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

8.  Vascular risk and FDDNP-PET influence cognitive performance.

Authors:  David A Merrill; Prabha Siddarth; Vladimir Kepe; Pushpa V Raja; Nathan Saito; Linda M Ercoli; Karen J Miller; Helen Lavretsky; Susan Y Bookheimer; Jorge R Barrio; Gary W Small
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

9.  Synergistic effects of ischemia and β-amyloid burden on cognitive decline in patients with subcortical vascular mild cognitive impairment.

Authors:  Mi Ji Lee; Sang Won Seo; Duk L Na; Changsoo Kim; Jae Hyun Park; Geon Ha Kim; Chi Hun Kim; Young Noh; Hanna Cho; Hee Jin Kim; Cindy W Yoon; Byoung Seok Ye; Juhee Chin; Seun Jeon; Jong-Min Lee; Yearn Seong Choe; Kyung-Han Lee; Jae Seung Kim; Sung Tae Kim; Jae-Hong Lee; Michael Ewers; David J Werring; Michael W Weiner
Journal:  JAMA Psychiatry       Date:  2014-04       Impact factor: 21.596

10.  Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study.

Authors:  M Edip Gurol; Anand Viswanathan; Christopher Gidicsin; Trey Hedden; Sergi Martinez-Ramirez; Andrew Dumas; Anastasia Vashkevich; Alison M Ayres; Eitan Auriel; Ellis van Etten; Alex Becker; Jeremy Carmasin; Kristin Schwab; Jonathan Rosand; Keith A Johnson; Steven M Greenberg
Journal:  Ann Neurol       Date:  2013-02-19       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.